Emergent BioSolutions Inc.EBSNYSE
Loading
Sum of short-term and long-term debt obligations
3Y CAGR
-26.3%/yr
vs +15.8%/yr prior
5Y CAGR
-9.1%/yr
Recent deceleration
Acceleration
-42.0pp
Decelerating
Percentile
P50
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
3 yr
Consecutive declineFair Value
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $572.10M | -15.4% |
| 2024 | $676.10M | -21.4% |
| 2023 | $860.20M | -39.7% |
| 2022 | $1.43B | +63.8% |
| 2021 | $871.00M | -5.6% |
| 2020 | $923.00M | +10.3% |
| 2019 | $836.90M | +5.3% |
| 2018 | $794.60M | +5804.7% |
| 2017 | $13.46M | -95.0% |
| 2016 | $268.09M | - |